Dimension Inx
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- $12M
Investors
- 6
About Dimension Inx
Based in Illinois, US, and founded in 2017, Dimension Inx, LLC designs and develops bioactive therapeutic products that restore tissue and organ function. The company through its biomaterials and manufacturing process develops and manufactures 3D-printed bioactive structures to drive bifunctionality and to treat human disease and debilitation including musculoskeletal health, and reproductive health. The company’s material provides a three-dimensional blueprint, that directs cells to behave as intended in bone regeneration, reproductive longevity, etc. Dimensions also work on the development of new materials for tissue therapeutics such as soft tissue restoration, and cell therapy delivery. The business intends to use its January 2023 fundraising to advance therapeutic development as well as scale the introduction of the company's pipeline of tissue and organ implants.
Who invested in Dimension Inx
6 investors across 1 round
See all investors in Dimension Inx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 23, 2023
Amount
$12M
Investors
Questions about Dimension Inx
Who invested in Dimension Inx?
Dimension Inx has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dimension Inx raised?
Dimension Inx has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Dimension Inx last raise money?
Dimension Inx's most recent round on record is a Series A, in Jan 2023.
What does Dimension Inx do?
Based in Illinois, US, and founded in 2017, Dimension Inx, LLC designs and develops bioactive therapeutic products that restore tissue and organ function.
Where is Dimension Inx headquartered?
Dimension Inx is headquartered in Chicago, US.
Which VCs invest in companies like Dimension Inx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Dimension Inx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Dimension Inx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.